SmithKline ends contract with Hyseq:
This article was originally published in Clinica
Hyseq and SmithKline Beecham Clinical Laboratories are stepping away from their agreement to develop jointly diagnostic technologies based on Hyseq's HyGnostics module, which uses sequencing by hybridisation. However, the two companies will consider future opportunities. SmithKline says it "looks forward to exploring ways in which we can commercialise Hyseq's technology".